A new study published in the January 2015 Investigative Ophthalmology & Visual Science has shared alarming news regarding patients who suffer from long-term or chronic hypertension. Information gleaned from studies has revealed that people who are diagnosed with hypertension and who do not treat their condition are at a heightened risk for glaucoma. Ophthalmologists and[…]
Long Term Hypertension Leads to Glaucoma and Brinzolamide is a Viable Treatment Option
Anti-Hypertensive, Drug Research & Development API Tags: glaucomahypertensionintraocular pressure May 29, 2015
Brimonidine Effectual for Soaring Rates of Glaucoma
Anti-Hypertensive, Drug Research & Development API Tags: glaucomaintraocular pressure May 14, 2015
By 2020 Glaucoma is predicted to affect over 80 million people worldwide as one of the leading causes of vision loss in adults. Approximately 10 percent of the patients diagnosed with Glaucoma will become bilaterally blind from this disease. Treatment to effectively and safely lower intraocular pressure is a must, with a growing rate of[…]
Bimatoprost Lower Intraocular Pressure and Increases Eyelash Growth
Drug Research & Development API, OTC and Compounding Product, Prostaglandin Tags: intraocular pressureprostaglandin May 11, 2015
Bimatoprost, CAS #155206-00-1 opthamolic solution has been known for being effectual at lowering intraocular pressure in adult patients. A new benefit of Bimatoprost has stolen the pharmaceutical headlines, however, with the advent of Latisse, for treating hypotrichosis of the eyelashes. Touted by long time movie star and model Brooke Shields, Latisse is recommended for[…]
FDA Approves Dorzolamide for Lowering Intraocular Pressure
Drug Research & Development API, FDA Approved 2014, OTC and Compounding Product Tags: glaucomahypertensionintraocular pressure May 04, 2015
In late 2014 the FDA approved Dorzolamide Hydrochloride, to be used in conjunction with Timolol Maleate for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Known as the brand name eye drop Cosopt Opthamolic Solution, which is marketed by Lannett Company Inc., this solution has proven to be both[…]
Betaxolol Remains a Standard Treatment for Ocular Hypertension
Drug Research & Development API Tags: Alconintraocular pressure Feb 26, 2015
The release of the Ocular Hypertension Pipeline Review, H2 2014 was encouraging for ophthalmologic research and development teams regarding the use of Betaxolol to treat ocular hypertension. The review, published in early 2015, focused on the positive aspects of various therapies for treating ocular hypertension, with Betaxolol receiving positive feedback. The global therapeutic landscape for[…]
FDA Approves Ketorolac and Phenylephrine for Eye Surgery
Anti-Inflammatory, Antibacterial, Drug Research & Development API, FDA Approved 2014, OTC and Compounding Product Tags: high blood pressureintraocular pressure Jun 09, 2014
Approximately four million Americans undergo cataract surgery every year, so the recent FDA approval of Ketorolac and Phenylephrine on June 2, 2014 is timely and beneficial for many patients in the United States. Known as the brand name Omidria, the combination of Ketorolac and Phenylephrine to create an efficacious pupil-dilating agent has been deemed successful[…]
Aflibercept Touted as 2013 Blockbuster Drug
Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API Tags: AfliberceptAMDEuropean Commissionintraocular pressure Jan 08, 2014
Aflibercept, also known as brand name Eyelea, has been recently touted as a 2013 blockbuster drug. With sales of Aflibercept in the United States thought to have surpassed 1.3 billion dollars in the 2013 calendar year, the pharmaceutical community has been optimistically awaiting final year end data. Marketed by Regeneron in the U.S., Eyelea {Aflibercept}[…]
Loteprednol Etabonate Safe for Children and Adults with Inflammatory Eye Conditions
Anti-Inflammatory, Drug Research & Development API Tags: allergic conjunctivitisintraocular pressureophthalmic Apr 19, 2012
Loteprednol Etabonate, also known as Lotemax, is an anti-inflammatory corticosteroid eye solution. As a prescription eye drop, loteprednol etabonate, CAS number 82034-46-6, is used to treat a variety of inflammatory eye conditions. These conditions typically affect the anterior chamber of the eye and include allergic conjunctivitis, superficial punctate keratitis, acne rosacea, Iritis, herpes zoster keratitis,[…]
Dorzolamide Hydrochloride Successfully Treats Open Angle Glaucoma
Bulk Active Ingredient, Drug Research & Development API, OTC and Compounding Product, TEVA API Tags: glaucomahypertensionintraocular pressure Mar 19, 2012
Dorzolamide Hydrochloride is an eye drop indicated for the treatment of ocular hypertension and open angle glaucoma. Also known by the trade names Trusopt and Cosopt, Dorzolamide Hydrochloride works by inhibiting the isoenzyme carbonic anhydrase, also termed CA-II. This inhibition helps to decrease the amount of fluid made within the eye, thus decreasing pressure in the affected[…]
